Your browser does not support JavaScript
 
Contrave Approved by the FDA for Weight Loss
Posted By: 
Friday, September 12, 2014

These are exciting days in the world of Clinical Research. On September 10th Contrave, a medication we are actively studying at Sterling Research, was approved by the FDA for weight loss. It is always satisfying when a study medication makes it to the market. Now, millions of people may benefit from Contrave. This accomplishment would not have been attained without the help of study volunteers. I commend all of the Medical Heroes that participate in Clinical Trials!

-Dr. Wenker




 

Blog Categories

  • News
    • 09/08/2017 - Gout Increasingly Common Among
    • 06/09/2017 - Understanding Fatty Liver
    • 03/28/2016 - Acne: More Than Just Pimples
    • 08/11/2015 - It's Coming...You Know It Is..
    • 02/10/2015 - Attorney General's Office Dema
    • 10/16/2014 - Regeneron, Sanofi drug slashes
    • 10/10/2014 - Ongoing Ebola Epidemic
    • 09/12/2014 - Contrave Approved by the FDA f
    • 07/11/2014 - Saxenda Recommended for Approv
    • 09/04/2013 - Only Half of Hypertensive Adul
  • Articles

Tag Cloud
 
 
Call for Participation
  Cincinnati / Mt. Auburn 
  Springdale 
Our Services
Patient Recruitment Specialist
Cincinnati, OH 

 (513) 621-5112
 (513) 621-5101
  2230 Auburn Avenue Level B 
Cincinnati, OH 45219 


 (513) 381-4100
 (513) 381-4120
  375 Glensprings Drive 2nd Flr
Cincinnati, OH 45246
 

 (513) 671-8080
 (513) 671-8090
About Us
Active Studies
Study Participants
About Clinical Trials
Sponsors/CROS
Blog
Careers

2020. STERLING RESEARCH. ALL RIGHTS RESERVED